139 related articles for article (PubMed ID: 23453731)
1. Different profile and distribution of antigen specific T cells induced by intranasal and intrarectal immunization with rotavirus 2/6-VLP with and without LT-R192G.
Alkadah A; Thiam F; Mounier M; Charpilienne A; Poncet D; Kohli E; Basset C
Vaccine; 2013 Apr; 31(15):1924-30. PubMed ID: 23453731
[TBL] [Abstract][Full Text] [Related]
2. Unexpected modulation of recall B and T cell responses after immunization with rotavirus-like particles in the presence of LT-R192G.
Thiam F; Martino CD; Bon F; Charpilienne A; Cachia C; Poncet D; Clements JD; Basset C; Kohli E
Toxins (Basel); 2010 Aug; 2(8):2007-27. PubMed ID: 22069670
[TBL] [Abstract][Full Text] [Related]
3. Association of gamma interferon and interleukin-17 production in intestinal CD4+ T cells with protection against rotavirus shedding in mice intranasally immunized with VP6 and the adjuvant LT(R192G).
Smiley KL; McNeal MM; Basu M; Choi AH; Clements JD; Ward RL
J Virol; 2007 Apr; 81(8):3740-8. PubMed ID: 17251301
[TBL] [Abstract][Full Text] [Related]
4. B subunits of cholera toxin and thermolabile enterotoxin of Escherichia coli have similar adjuvant effect as whole molecules on rotavirus 2/6-VLP specific antibody responses and induce a Th17-like response after intrarectal immunization.
Thiam F; Charpilienne A; Poncet D; Kohli E; Basset C
Microb Pathog; 2015 Dec; 89():27-34. PubMed ID: 26318874
[TBL] [Abstract][Full Text] [Related]
5. Mice develop effective but delayed protective immune responses when immunized as neonates either intranasally with nonliving VP6/LT(R192G) or orally with live rhesus rotavirus vaccine candidates.
VanCott JL; Prada AE; McNeal MM; Stone SC; Basu M; Huffer B; Smiley KL; Shao M; Bean JA; Clements JD; Choi AH; Ward RL
J Virol; 2006 May; 80(10):4949-61. PubMed ID: 16641286
[TBL] [Abstract][Full Text] [Related]
6. CD4 T cells are the only lymphocytes needed to protect mice against rotavirus shedding after intranasal immunization with a chimeric VP6 protein and the adjuvant LT(R192G).
McNeal MM; VanCott JL; Choi AH; Basu M; Flint JA; Stone SC; Clements JD; Ward RL
J Virol; 2002 Jan; 76(2):560-8. PubMed ID: 11752147
[TBL] [Abstract][Full Text] [Related]
7. Protection against rotavirus shedding after intranasal immunization of mice with a chimeric VP6 protein does not require intestinal IgA.
McNeal MM; Stone SC; Basu M; Bean JA; Clements JD; Hendrickson BA; Choi AH; Ward RL
Virology; 2006 Mar; 346(2):338-47. PubMed ID: 16375942
[TBL] [Abstract][Full Text] [Related]
8. IFN-gamma is the only anti-rotavirus cytokine found after in vitro stimulation of memory CD4+ T cells from mice immunized with a chimeric VP6 protein.
McNeal MM; Stone SC; Basu M; Clements JD; Choi AH; Ward RL
Viral Immunol; 2007 Dec; 20(4):571-84. PubMed ID: 18158731
[TBL] [Abstract][Full Text] [Related]
9. Intrarectal immunization of mice with VP6 and either LT(R192G) or CTA1-DD as adjuvant protects against fecal rotavirus shedding after EDIM challenge.
McNeal MM; Basu M; Bean JA; Clements JD; Lycke NY; Ramne A; Löwenadler B; Choi AH; Ward RL
Vaccine; 2007 Aug; 25(33):6224-31. PubMed ID: 17629371
[TBL] [Abstract][Full Text] [Related]
10. Intranasal administration of 2/6-rotavirus-like particles with mutant Escherichia coli heat-labile toxin (LT-R192G) induces antibody-secreting cell responses but not protective immunity in gnotobiotic pigs.
Yuan L; Geyer A; Hodgins DC; Fan Z; Qian Y; Chang KO; Crawford SE; Parreño V; Ward LA; Estes MK; Conner ME; Saif LJ
J Virol; 2000 Oct; 74(19):8843-53. PubMed ID: 10982326
[TBL] [Abstract][Full Text] [Related]
11. The level of protection against rotavirus shedding in mice following immunization with a chimeric VP6 protein is dependent on the route and the coadministered adjuvant.
Choi AH; McNeal MM; Flint JA; Basu M; Lycke NY; Clements JD; Bean JA; Davis HL; McCluskie MJ; VanCott JL; Ward RL
Vaccine; 2002 Mar; 20(13-14):1733-40. PubMed ID: 11906760
[TBL] [Abstract][Full Text] [Related]
12. Rectal immunization with rotavirus virus-like particles induces systemic and mucosal humoral immune responses and protects mice against rotavirus infection.
Parez N; Fourgeux C; Mohamed A; Dubuquoy C; Pillot M; Dehee A; Charpilienne A; Poncet D; Schwartz-Cornil I; Garbarg-Chenon A
J Virol; 2006 Feb; 80(4):1752-61. PubMed ID: 16439532
[TBL] [Abstract][Full Text] [Related]
13. Distribution and phenotype of rotavirus-specific B cells induced during the antigen-driven primary response to 2/6 virus-like particles administered by the intrarectal and the intranasal routes.
Di Martino C; Basset C; Ogier A; Charpilienne A; Poncet D; Kohli E
J Leukoc Biol; 2007 Oct; 82(4):821-8. PubMed ID: 17652448
[TBL] [Abstract][Full Text] [Related]
14. Induction of immune responses and partial protection in mice after skin immunization with rotavirus VP6 protein and the adjuvant LT(R192G).
Choi AH; Smiley K; Basu M
Vaccine; 2005 Mar; 23(17-18):2290-3. PubMed ID: 15755613
[TBL] [Abstract][Full Text] [Related]
15. Antibody-dependent and -independent protection following intranasal immunization of mice with rotavirus particles.
McNeal MM; Rae MN; Bean JA; Ward RL
J Virol; 1999 Sep; 73(9):7565-73. PubMed ID: 10438846
[TBL] [Abstract][Full Text] [Related]
16. Protective immunity and antibody-secreting cell responses elicited by combined oral attenuated Wa human rotavirus and intranasal Wa 2/6-VLPs with mutant Escherichia coli heat-labile toxin in gnotobiotic pigs.
Yuan L; Iosef C; Azevedo MS; Kim Y; Qian Y; Geyer A; Nguyen TV; Chang KO; Saif LJ
J Virol; 2001 Oct; 75(19):9229-38. PubMed ID: 11533185
[TBL] [Abstract][Full Text] [Related]
17. Targeting of rotavirus VP6 to DEC-205 induces protection against the infection in mice.
Badillo-Godinez O; Gutierrez-Xicotencatl L; Plett-Torres T; Pedroza-Saavedra A; Gonzalez-Jaimes A; Chihu-Amparan L; Maldonado-Gama M; Espino-Solis G; Bonifaz LC; Esquivel-Guadarrama F
Vaccine; 2015 Aug; 33(35):4228-37. PubMed ID: 25850020
[TBL] [Abstract][Full Text] [Related]
18. Distribution and phenotype of murine rotavirus-specific B cells induced by intranasal immunization with 2/6 virus-like particles.
Ogier A; Franco MA; Charpilienne A; Cohen J; Pothier P; Kohli E
Eur J Immunol; 2005 Jul; 35(7):2122-30. PubMed ID: 15948217
[TBL] [Abstract][Full Text] [Related]
19. Identification of an immunodominant CD4+ T cell epitope in the VP6 protein of rotavirus following intranasal immunization of BALB/c mice.
McNeal MM; Basu M; Bean JA; Clements JD; Choi AH; Ward RL
Virology; 2007 Jul; 363(2):410-8. PubMed ID: 17337285
[TBL] [Abstract][Full Text] [Related]
20. Development of a Bacillus subtilis-based rotavirus vaccine.
Lee S; Belitsky BR; Brinker JP; Kerstein KO; Brown DW; Clements JD; Keusch GT; Tzipori S; Sonenshein AL; Herrmann JE
Clin Vaccine Immunol; 2010 Nov; 17(11):1647-55. PubMed ID: 20810679
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
